Use of gelatin-thrombin matrix haemostatic sealant in neurosurgery: Anaesthetic implications and review of literature

Abstract

The topical haemostatic agents have been developed to be used as adjunctive measures to promote haemostasis. These include bone wax, absorbable gel sponges, microfibrillar collagen, oxidised regenerated cellulose, gelatin sponges with thrombin, gelatin-thrombin matrix sealant or fibrin sealants. Gelatin-thrombin matrix sealant is a mixture of a bovine-derived gelatin matrix and human-derived thrombin component that are mixed together at the time of use. This agent has been found to be more effective haemostat than thrombin-soaked gelatine sponges. The possible adverse effects of this can be transmission of diseases from human or bovine sources, allergic reactions, thromboembolism, disseminated intravascular coagulopathy (DIC), perilesional oedema, and compression of neural tissue. Although it is used routinely in the operating room, there is little literature available on the perioperative implications with use of intraoperative gelatin-thrombin matrix sealant. Here, we present clinical report of 20 neurosurgical patients where the sealant was used and literature in view of current evidence has been reviewed.

Keywords

Anaesthesia - haemostatic sealant - intraoperative bleeding - neurosurgery

• REFERENCES

• 1 Oz MC, Rondinone JF, Shargill NS. Floseal Matrix: New generation topical hemostatic sealant. J Card Surg 2003; 18: 486-93
• 2 Spotnitz WD, Burks S. State-of-the-Art Review: Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 2010; 16: 497-514
• 3 Pusateri AE, Holcomb JB, Bhattacharyya SN, Harris RA, Gomez RR, MacPhee MJ. et al. Different hypotensive responses to intravenous bovine and human thrombin preparations in swine. J Trauma 2001; 50: 83-90
• 4 Gabay M. Absorbable hemostatic agents. Am J Health Syst Pharm 2006; 63: 1244-53
• 5 Gershon SK, Chang AC, Purvis WV, Salive M. Misadministration of topical bovine thrombin. JAMA 1999; 282: 1919
• 6 Kajitani M, Ozdemir A, Aguinaga M, Jazieh AR, Flick JT, Antakli T. Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product. J Card Surg 2000; 15: 378-82
• 7 Levi M. Disseminated intravascular coagulation. Crit Care Med 2007; 35: 2191-5
• 8 Yao HH, Hong MK, Drummond KJ. Haemostasis in neurosurgery: What is the evidence for gelatin-thrombin matrix sealant?. J Clin Neurosci 2013; 20: 349-56
• 9 Steinestel K, Geiger A, Naraghi R, Kunz U, Danz B, Kraft K. et al. Fatal thromboembolism to the left pulmonary artery by locally applied hemostatic matrix after surgical removal of spinal schwannoma: A case report. Hum Pathol 2013; 44: 294-8
• 10 Spencer HT, Hsu JT, McDonald DR, Karlin LI. Intraoperative anaphylaxis to gelatin in topical hemostatic agents during anterior spinal fusion: A case report. Spine J 2012; 12: e1-6
• 11 Mozet C, Prettin C, Dietze M, Fickweiler U, Dietz A. Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: Randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol 2012; 269: 2247-54
• 12 Lemmer R, Albrech M, Bauer G. Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage. J Obstet Gynaecol Res 2012; 38: 435-7
• 13 Gorry A, Morelli ML, Olowu O, Shahid A, Odejinmi F. Laparoscopic management of abdominal ectopic pregnancy using FLOSEAL Hemostatic Matrix. Int J Gynaecol Obstet 2012; 117: 83-4
• 14 Ujam A, Awad Z, Wong G, Tatla T, Farrell R. Safety trial of Floseal haemostatic agent in head and neck surgery. Ann R Coll Surg Engl 2012; 94: 336-9